Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lev-El Diagnostics is an Israeli med-tech company focused on noninvasive detection of cardiovascular disease. Its lead and apparently core commercial product is HeartTrends, a software-enabled cardiac screening test that analyzes heart-rate variability from prerecorded ambulatory ECG or heart-rate recorder data to help detect myocardial ischemia without exercise stress. The company positions HeartTrends as an alternative to conventional cardiac stress testing for early screening, especially in relatively healthy individuals and routine settings. Public materials indicate the product is CE-marked in Europe, and the company also references FDA clearance for HeartTrends software. Overall, Lev-El Diagnostics appears to be a small private cardiovascular diagnostics company built around a single proprietary diagnostic platform rather than a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lev-El Diagnostics.